Cosmo Pharmaceuticals is seeking to move its headquarters to Luxembourg as the Italian drug maker looks for a lower-tax environment, after a planned $2.7 billion merger with a U.S. company fell through.
Reported by Wall Street Journal 2 hours ago.
↧